Trade BLTE anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Belite Bio, Inc American Depositary Shares (BLTE) is trading at US$153.13, down 2.47% today as of Aug 28, 12:58 EDT. The company has a market capitalisation of US$6.49B. Over the past 52 weeks, BLTE has traded between US$62.18 and US$200.00. On Syfe you can trade BLTE with $0 commission and add it to your watchlist.
| Previous close | US$157.01 |
|---|---|
| Market cap | US$6.49B |
| P/E ratio | 3368.87 |
| 52-week range | US$62.18 – US$200.00 |
| Volume | 90.21K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Belite Bio, Inc American Depositary Shares
Belite Bio, Inc. engages in the research and development of drugs. It focuses on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.
Year: 2022
Belite Bio Insider Sold Shares Worth $1,405,729, According to a Recent SEC Filing
Jun 17, 10:09 AM · MT Newswires
Mizuho Adjusts Price Target on Belite Bio to $215 From $223, Maintains Outperform Rating
May 26, 10:27 AM · MT Newswires
Stay on top of BLTE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
